Login / Signup

Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.

Marc-Kevin Le RouxNicolas GraillonLaurent GuyotDavid TaïebPhilippe GalliYves Godio-RaboutetCyrille ChossegrosJean-Marc Foletti
Published in: Head & neck (2020)
Our study suggests that a significant rate of patients will recover from I131 therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow-up, we highlight the necessity of a long-term follow-up in these patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • squamous cell carcinoma